CINCINNATI--(BUSINESS WIRE)--Jul. 2, 2013--
Bioline, The PCR Company, a wholly-owned subsidiary of Meridian
Bioscience, Inc. (NASDAQ:VIVO), is proud to announce the worldwide
release of the MyTaqTM Extract-PCR Kit.
Powered by the high performance MyTaqTM DNA Polymerase, the
MyTaqTM Extract-PCR Kit offers a quick and easy alternative
for the extraction and amplification of DNA from a variety of mammalian
tissue types. Researchers using the MyTaqTM Extract-PCR Kit
can replace complicated and time consuming extraction methods with a
simple 15 minute, single tube, protocol; making it perfect for high
throughput applications, such as mouse genotyping and sequencing.
Marco Calzavara, President of Bioline commented, "With the MyTaqTM
Extract-PCR Kit; researchers can now quickly achieve the purity and
yield necessary for high-performance PCR and real time PCR experiments
from solid tissues, such as mouse tail or mouse ear. This makes MyTaqTM
extract the perfect addition to our widely used PCR reagents.”
Richard L. Eberly, President of Meridian Life Science, Inc., stated, “We
are delighted to release the MyTaqTM Extract-PCR Kit, another
product in the rapidly expanding portfolio of highly specialized
molecular biology reagents from Bioline. We are committed to our life
science customers and to bringing innovation and quality products; such
as the family of MyTaq™ products to the research laboratory, clinical
diagnostic laboratories, and biotechnology companies.”
ABOUT MERIDIAN BIOSCIENCE, INC.
Meridian is a fully integrated life science company that develops,
manufactures, markets and distributes a broad range of innovative
diagnostic test kits, purified reagents and related products and offers
biopharmaceutical enabling technologies. Utilizing a variety of methods,
these products and diagnostic tests provide accuracy, simplicity and
speed in the early diagnosis and treatment of common medical conditions,
such as gastrointestinal, viral and respiratory infections. Meridian’s
diagnostic products are used outside of the human body and require
little or no special equipment. The Company's products are designed to
enhance patient well-being while reducing the total outcome costs of
healthcare. Meridian has strong market positions in the areas of
gastrointestinal and upper respiratory infections, serology,
parasitology and fungal disease diagnosis. In addition, Meridian is a
supplier of rare reagents, specialty biologicals and related
technologies used by biopharmaceutical companies engaged in research for
new drugs and vaccines. The Company markets its products and
technologies to hospitals, reference laboratories, research centers,
diagnostics manufacturers and biotech companies in more than 60
countries around the world. The Company’s shares are traded on NASDAQ’s
Global Select Market, symbol VIVO. Meridian's website address is www.meridianbioscience.com.
ADDITIONAL INFORMATION
For more information about Bioline, please
visit www.bioline.com
For
more information about Meridian Life Science, Inc., please visit www.meridianlifescience.com
For
more information about Meridian Bioscience, Inc., please visit www.meridianbioscience.com
Richard
L. Eberly, rick.eberly@meridianbioscience.com

Source: Meridian Bioscience, Inc.
Meridian Bioscience, Inc.
Richard L. Eberly, 513-271-3700